This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:cancer [04.06.2019] – [Toll-like receptor 9 (TLR9) agonists] sallieq | home:diseases:cancer [04.07.2019] – [Are There Concerns About Supplementing with Vitamin D?] sallieq | ||
---|---|---|---|
Line 28: | Line 28: | ||
With the recent advent of high throughput sequencing studies, we can expect additional insights into how diseases like cancer are associated with shifts in microbial communities. | With the recent advent of high throughput sequencing studies, we can expect additional insights into how diseases like cancer are associated with shifts in microbial communities. | ||
- | ==== see also M P Study Site Discussion | + | ==== see also M P Study Site ==== |
[[https:// | [[https:// | ||
Line 75: | Line 75: | ||
- | ==== Are There Concerns About Supplementing with Vitamin | + | ==== Are There Concerns About V.D Supplement |
There is a common misconception that vitamin D supplementation is safe at any reasonable level, or that if some is good, more may be better. | There is a common misconception that vitamin D supplementation is safe at any reasonable level, or that if some is good, more may be better. | ||
Line 243: | Line 243: | ||
[[http:// | [[http:// | ||
+ | ==== Toll-like receptor 9 (TLR9) agonists ==== | ||
+ | |||
+ | The activity and safety of these novel anticancer agents are being explored in a wide range of tumor types as part of a variety of therapeutic strategies with the goal of harnessing the immune response to fight cancer. | ||
+ | |||
+ | Activation of Toll-Like Receptor 9 by DNA from Different Bacterial Species | ||
====Vaccines==== | ====Vaccines==== | ||